The present invention relates to insulin derivatives having a built-in glucose sensor and a polyol moiety, capable to deliver insulin from an injected depot of an insulin derivative according to the invention as a function of the glucose concentration in the surrounding tissue.
[EN] PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS<br/>[FR] PYRAZOLOPYRIMIDINES EN TANT QU'AGENTS THERAPEUTIQUES
申请人:BASF AG
公开号:WO2001019829A2
公开(公告)日:2001-03-22
The present invention provides compounds of Formula (I), including pharmaceutically acceptable salts and/or prodrugs thereof, where G, Ra, R2, R3 are defined as described herein and their use as protein Kinase inhibitors.